Uterine sarcomas have high rates of somatic mutations in homologous recombination DNA damage response, which has been associated with lower progression-free survival (PFS) rates on standard first ...

State of the Art: Personalizing Treatment for Patients With Metastatic Castration-Resistant Prostate Cancer Doxorubicin plus trabectedin followed by trabectedin maintenance showed a survival advantage ...

Uterine sarcomas are rare, aggressive tumors with limited chemotherapy responsiveness. Poly(ADP-ribose) polymerase inhibitors (PARPis) have emerged as targeted therapies for patients with BRCA ...

Uterine sarcoma is rare (3–7 per 100,000 in the US population) with a poor prognosis. Leiomyosarcomas are the most common of the uterine sarcomas. A US FDA report estimated the prevalence of ...

There are sensitive preoperative screening tests to detect cervical, endometrial and ovarian occult malignancies but none exists to detect uterine sarcomas. There is almost a complete lack of ...

Uterine fibroids, or leiomyomas, present diagnostic challenges due to symptom overlap with rare but aggressive ...

Uterine leiomyosarcoma may be rare, but awareness can save lives. If you or someone you love is experiencing persistent or ...

A Surrey grandmother who was initially sent home from hospital with painkillers was actually living with a rare 4.5 kilo ...

A “crisis” in cancer treatment wait times has prompted the opening of a second operating room for gynecological cancers at ...

A single blood test, designed to pick up chemical signals indicative of the presence of many different types of cancer, could potentially thwart ...